4//SEC Filing
Smith Brendan 4
Accession 0000899243-21-016406
CIK 0001693415other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:49 PM ET
Size
5.5 KB
Accession
0000899243-21-016406
Insider Transaction Report
Form 4
Smith Brendan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+201,800→ 201,800 totalExercise: $19.23Exp: 2031-04-18→ Common Stock (201,800 underlying)
Footnotes (1)
- [F1]This option was granted on April 19 2021. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on April 19, 2022 and the remainder vesting in equal monthly installments through April 19, 2025.
Documents
Issuer
Translate Bio, Inc.
CIK 0001693415
Entity typeother
Related Parties
1- filerCIK 0001857492
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 4:49 PM ET
- Size
- 5.5 KB